GLP - 1 inhibition

Search documents
Amylyx Pharmaceuticals (AMLX) 2025 Conference Transcript
2025-09-03 13:02
Amylyx Pharmaceuticals (AMLX) 2025 Conference September 03, 2025 08:00 AM ET Company ParticipantsJustin Klee - Co-Founder, Co-CEO & DirectorJosh Cohen - Co-Founder, Co-CEO & DirectorJustin KleeThree years on average after the bariatric surgery, people will develop this very persistent symptomatic hypoglycemia. What does that mean? When we're talking about this sort of severe hypoglycemia, the medical term is neuroglycopenia. It means that the blood sugar gets to a level where the nervous system stops functi ...